as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
1.15%
Downside
5.64%
Upside
52 Week's Low
52 Week's High
21.29%
Downside
5.64%
Upside
Check Edwards Lifesciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$48.4B
EPS (TTM)
2.5971
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.07%
PE Ratio (TTM)
34.5
Industry PE ratio
19.200384615384614
PEG Ratio
4.1293
EBITDA
1.7B
Revenue (TTM)
5.7B
Profit Margin
72.96%
Return On Equity TTM
15.53%
Track how Edwards Lifesciences Corp. P/E has moved over time to understand its valuation trends.
Edwards Lifesciences Corp. in the last 5 years
Lowest (26.71x)
December 31, 2024
Industry (19.20x)
November 1, 2025
Today (34.50x)
November 1, 2025
Highest (52.31x)
December 31, 2021
Today’s Price to Earnings Ratio: 34.50x
Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $48.4B | 15.01% | 34.5 | 72.96% | |
| BUY | $149.0B | 193.9% | 53.78 | 14.43% | |
| BUY | $141.1B | 76.35% | 48.81 | 12.25% | |
| BUY | $216.8B | 17.61% | 15.68 | 31.88% | |
| BUY | $116.7B | -9.81% | 25.13 | 13.63% |
The Edwards Lifesciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Edwards Lifesciences Corp. investment value today
Current value as on today
₹1,27,703
Returns
₹27,703
(+27.7%)
Returns from Edwards Lifesciences Corp. Stock
₹22,061 (+22.06%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 40 analysts
60.00%
Buy
35.00%
Hold
5.00%
Sell
Based on 40 analysts, 60% of analysts recommend a 'BUY' rating for Edwards Lifesciences Corp.. Average target price of $92.5
Get share price movements and forecasts by analysts on Edwards Lifesciences Corp..
What analysts predicted
10.88%UPSIDE
Target Price
$92.5
Current Price
$82.44
Analyzed by
40 Analysts
Target
$92.50
Edwards Lifesciences Corp. target price $92.5, a slight upside of 10.88% compared to current price of $82.44. According to 40 analysts rating.
Search interest for Edwards Lifesciences Corp. Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:35%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 29 October
Wed, 05:39 PM
-Jefferies upgrades Edwards Lifesciences to Buy, citing strong positioning for share gains in the growing TAVR market.
Thu, 05:44 AM
-Analysts express cautious optimism for Edwards Lifesciences, highlighting positive clinical data and evolving market expectations.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Edwards Lifesciences Corp. has shown consistent revenue growth over the past four quarters, increasing from $1.35 billion to $1.53 billion. This represents an average quarterly increase of 4.0%.
Best in 1 Year
![]()
In the last 1 year, EW has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 7 days, EW stock has moved up by 9.7%
Best in 3 Years
![]()
In the last 3 years, EW has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
![]()
Edwards Lifesciences Corp. has experienced a decline in net profit over the last four quarters. The profit dropped significantly from $3.07 billion to $329.8 million, averaging a decrease of 34.2% each quarter.
| Organisation | Edwards Lifesciences Corp. |
| Headquarters | One Edwards Way, Irvine, CA, United States, 92614 |
| Industry | Health Technology |
| CEO | Mr. Bernard J. Zovighian |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
Dr. Todd J. Brinton FACC, M.D. | Corporate VP of Advanced Technology & Chief Scientific Officer |
Mr. Mark D. Peterson | Corporate VP & General Counsel |
Mr. Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China |
Mr. Scott B. Ullem | Corporate VP & CFO |
Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
Mr. Mark Wilterding | Vice President of Investor Relations |
Mr. Dirksen J. Lehman | Corporate Vice President of Public Affairs |
Mr. Bernard J. Zovighian | CEO & Director |
Edwards Lifesciences Corp. share price today is $82.44 as on at the close of the market. Edwards Lifesciences Corp. share today touched a day high of $87.09 and a low of $81.49.
Edwards Lifesciences Corp. share touched a 52 week high of $87.09 on and a 52 week low of $64.89 on . Edwards Lifesciences Corp. stock price today i.e. is closed at $82.44,which is 5.34% down from its 52 week high and 27.05% up from its 52 week low.
Edwards Lifesciences Corp. market capitalisation is $0.05T as on .
Indian investors can start investing in Edwards Lifesciences Corp. (EW) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.65 in Edwards Lifesciences Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Edwards Lifesciences Corp. share’s latest price of $82.44 as on November 1, 2025 at 1:29 am IST, you will get 0.1213 shares of Edwards Lifesciences Corp.. Learn more about
fractional shares .
Edwards Lifesciences Corp. stock has given 15.01% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?